More than 150 participants from 27 countries attended this year's SCHWIND User Meeting in Muscat, Oman.
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.
Brazil’s ANVISA grants marketing authorization to Lucentis biosimilar FYB201 (Ranivisio, Formycon/Bioeq AG)
The biopharmaceutical is the first biosimilar to ranibizumab (Genentech Inc.) approved in Brazil
Higher Molar Dose and Its Translation into Clinical Practice
An implantable option bridges the gap for patients with AMD
Long-term benefits and vision preservation using an extended macular vision IOL
Unveiling genetic distinctions between reticular pseudodrusen and drusen
Insights from a genome-wide association study identify novel genetic loci
Pinpointing a first-line treatment for glaucoma
Laser surgery is an appropriate adjunctive therapy across the continuum of glaucoma care, as well as a safe option for patients who also have cataracts and other complicating factors
EU issues CE mark for AI therapy planning assistant from deepeye Medical
The therapy planning support tool has been trained on thousands of patient cases from more than 200 retina centres throughout Europe